US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist

0.371
+0.049+15.06%

Close Dec 27 16:00 ET

0.380
+0.009+2.32%

Post 20:01 ET

20.50MMarket Cap-0.15P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marinus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 10.484M	--
--	2024/Q4	-- / 10.368M	--
--	2024/Q3	8.541M / 9.422M	--
Aug 13, 2024	2024/Q2	8.056M / 9.507M	--
May 8, 2024	2024/Q1	7.679M / 9.089M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 10.484M--

--2024/Q4-- / 10.368M--

--2024/Q38.541M / 9.422M--

Aug 13, 20242024/Q28.056M / 9.507M--

May 8, 20242024/Q17.679M / 9.089M--

Unlock Free Earnings Estimates

Open Account

Marinus Pharmaceuticals Earnings Reports

Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 12 16:46 ET

Marinus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:16 ET

Marinus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 13 08:02 ET

Marinus Pharmaceuticals | 8-K: Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 13 07:13 ET

Analyst Rating

Updated: Dec 28, 2024

Buy

Buy
42.86%
Hold
57.14%
Sell
0.00%

Price Target

No Data

Heat List

Overall